1. Home
  2. DLHC vs XBIT Comparison

DLHC vs XBIT Comparison

Compare DLHC & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DLH Holdings Corp.

DLHC

DLH Holdings Corp.

N/A

Current Price

$5.85

Market Cap

83.8M

ML Signal

N/A

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$2.36

Market Cap

71.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DLHC
XBIT
Founded
1969
2005
Country
United States
United States
Employees
2300
N/A
Industry
Business Services
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.8M
71.6M
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
DLHC
XBIT
Price
$5.85
$2.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.6K
24.8K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$41,923,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.57
N/A
52 Week Low
$2.72
$2.09
52 Week High
$8.09
$3.62

Technical Indicators

Market Signals
Indicator
DLHC
XBIT
Relative Strength Index (RSI) 51.90 47.18
Support Level $5.52 $2.32
Resistance Level $5.96 $2.69
Average True Range (ATR) 0.16 0.10
MACD 0.02 0.01
Stochastic Oscillator 70.00 60.48

Price Performance

Historical Comparison
DLHC
XBIT

About DLHC DLH Holdings Corp.

DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: